Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatm... by Kejia Zhu, Kejia Zhu, Kejia Zhu, Kejia Zhu, Yao Chang, Yao Chang, Delong Zhao, Andong Guo, Jishuang Cao, Chenrui Wu, Yong Guan, Yong Guan, Yong Guan, Sentai Ding, Sentai Ding, Sentai Ding

Connect to this object online.